Status:
COMPLETED
Oral Acetazolamide, Brimonidine Tartarate, and Anterior Chamber Paracentesis for Ocular Hypertension Control After Intravitreal Bevacizumab
Lead Sponsor:
University of Sao Paulo
Collaborating Sponsors:
Fundação de Apoio ao Ensino Pesquisa e Assitência do HCFMRPUSP
Conditions:
Age Related Macular Degeneration
Diabetic Retinopathy
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
The purpose of this study is to evaluate the effects of anterior chamber paracentesis, brimonidine and oral acetazolamide to reduce intra-ocular pressure variations after intravitreal bevacizumab inje...
Eligibility Criteria
Inclusion
- Diagnosis of age related macular disease or diabetic retinopathy
- Able and willing to provide informed consent
Exclusion
- History of ocular hypertension or glaucoma
- High Myopes (\> 6 spherical diopters)
- High Hyperopes (\> 4 spherical diopters)
- Pulmonary disease
- Renal disease
- Known allergy to any component of the study drug
- Myocardial infarction, transient ischemic attack within 4 months prior to randomization or any contraindication for bevacizumab use
Key Trial Info
Start Date :
June 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2009
Estimated Enrollment :
56 Patients enrolled
Trial Details
Trial ID
NCT00864838
Start Date
June 1 2008
End Date
March 1 2009
Last Update
March 19 2009
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.